Alzamend Neuro(DE:9ZT)
€194.400.00 (0.00%)
DE:9ZT
Alzamend Neuro ownership
€194.40
At close:0.00 (0.00%)
Alzamend Neuro (9ZT) Ownership - Who Owns Alzamend Neuro?
2 Followers
Alzamend Neuro (9ZT) Ownership Overview
- 2.65% Insiders
- 0.77% Mutual Funds
- 23.22% Other Institutional Investors
- 0.75% ETFs
- 72.62% Public Companies and Individual Investors
The ownership structure of Alzamend Neuro (DE:9ZT) stock is a mix of institutional, retail, and individual investors. Approximately 24.74% of the company’s stock is owned by Institutional Investors, 2.65% is owned by Insiders, and 72.62% is owned by Public Companies and Individual Investors.
The ownership structure of Alzamend Neuro (DE:9ZT) stock is a mix of institutional, retail, and individual investors. Approximately 24.74% of the company’s stock is owned by Institutional Investors, 2.65% is owned by Insiders, and 72.62% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 30, 2026 | Milton C Iii Ault | $3,100 | |
| Apr 15, 2026 | Milton C Iii Ault | $108,388 | |
| Dec 29, 2025 | Milton C Iii Ault | $3,813 | |
| Dec 22, 2025 | William B. Horne | $7,033 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Milton C Iii Ault | 127,777 | Insider | 2.65% | 27,304,284 |
| Vanguard | 36,204 | Institution | 0.75% | 7,736,324 |
| Fidelity Concord Street Trust | 24,502 | Institution | 0.51% | 5,235,759 |
| Vanguard Index Funds | 7,556 | Institution | 0.16% | 1,614,619 |
| Victory Portfolios Iii | 5,077 | Institution | 0.11% | 1,084,889 |
| BlackRock, Inc. | 437 | Institution | <0.01% | 93,381 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Concord Street Trust | 24,502 | Institution | 0.51% | 5,235,759 |
| Vanguard Index Funds | 7,556 | Institution | 0.16% | 1,614,619 |
| Victory Portfolios Iii | 5,077 | Institution | 0.11% | 1,084,889 |
FAQ
Who Owns Alzamend Neuro (DE:9ZT)?
According to the latest TipRanks data, approximately 24.74% of the company's stock is held by institutional investors, 2.65% is held by insiders, and 72.62% is held by public companies and individual investors.
What percentage of Alzamend Neuro (DE:9ZT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.74% of Alzamend Neuro (DE:9ZT) stock is held by institutional investors: 0.77% by mutual funds, 0.75% by ETFs and 23.22% by other institutional investors.
What percentage of Alzamend Neuro (DE:9ZT) stock is held by retail investors?
According to the latest TipRanks data, approximately 72.62% of Alzamend Neuro (DE:9ZT) stock is held by public companies and individual investors.
Who owns the most shares of Alzamend Neuro (DE:9ZT)?
MILTON C III AULT owns the most shares of Alzamend Neuro (DE:9ZT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

